The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

A team of researchers made a breakthrough in the search for treatments for multiple sclerosis (MS) and other ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

Symptoms that steadily get worse from the onset of the condition indicate a progressive form of MS. There’s no cure for MS yet, but treatment can help manage symptoms, treat relapses ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

TG Therapeutics exceeded 2024 revenue guidance by 24%, signaling strong growth. Read more to see why I rate TGTX stock a ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and ...

The drug could aid in the restoration of vision in those suffering from multiple sclerosis (MS) and other neurodegenerative ...